Compare Exelon Corporation Common Stock (EXC) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Exelon Corporation Common Stock vs State Street SPDR S&P Biotech ETF — how do they compare? Exelon Corporation Common Stock trades at $41.73 (market cap $42.99B), while State Street SPDR S&P Biotech ETF trades at $153.81 (market cap $10.11B). The key difference: Exelon Corporation Common Stock is far larger — about 4.3× State Street SPDR S&P Biotech ETF's market cap, and Exelon Corporation Common Stock pays a 4.03% dividend while State Street SPDR S&P Biotech ETF pays none. Which is the better fit depends on your goals.
| EXC | XBI | |
|---|---|---|
Market Cap | $42.99B | $10.11B |
Volume | 7,570,408 | 12,903,266 |
Sector | Utilities | Broad Market / Factor |
52-Week High | $50.29 | $169.55 |
52-Week Low | $40.20 | $104.99 |
Enterprise Value | $93.85B | — |
Dividend Yield | 4.03% | — |
Typical Hold Time | — | 38 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XBI trades at $153.75, up 2.34% today, but technical indicators signal a bearish trend with resistance at $154. The ETF's modified equal-weight structure provides exposure to over 150 biotech companies, benefiting from M&A activity and positive clinical catalysts like the Merck-Moderna cancer vaccine breakthrough.
Outlook remains mixed with 100% analyst hold rating contrasting with bullish news catalysts. Key risks include high volatility, sector-specific regulatory pressures, and expense ratios higher than broader healthcare ETFs. The current technical setup near resistance requires monitoring for breakout confirmation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Exelon Corporation Common Stock
Exelon is the parent company of six regulated electric and natural gas utilities. Its utilities include Atlantic City Electric, BGE, ComEd, Delmarva Power, PECO, and Pepco.
Read more on EXC →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
